Detalles de la búsqueda
1.
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.
Haematologica
; 93(12): 1829-36, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18945747
2.
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression.
Haematologica
; 93(4): 560-5, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18322252
3.
Lenalidomide treatment for patients with multiple myeloma: diagnosis and management of most frequent adverse events.
Adv Ther
; 28 Suppl 1: 11-6, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21431627
4.
Absence of clinically relevant effect of caspofungin on cyclosporin pharmacokinetics.
Swiss Med Wkly
; 135(43-44): 658-9, 2005 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-16380854
5.
Phase II PETHEMA trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kinetics.
J Clin Oncol
; 25(28): 4452-8, 2007 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17785704
Resultados
1 -
5
de 5
1
Próxima >
>>